Complete Cost Comparison: Wegovy vs Mounjaro Monthly UK
Monthly Cost Analysis When Switching From Wegovy to Mounjaro UK
When switching from Wegovy to Mounjaro UK, understanding the monthly cost implications becomes essential for budgeting your weight management journey. Wegovy follows a structured 16-week dose escalation protocol, with monthly costs ranging from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. Mounjaro operates on a similar escalation schedule but with different pricing tiers reflecting its dual-agonist mechanism. The key consideration isn't just the immediate monthly outlay, but the long-term financial commitment required for sustained weight management support.
Both medications represent significant monthly investments, making it crucial to evaluate which treatment aligns with your clinical needs and budget constraints. EverydayMeds provides transparent pricing for both options, ensuring patients can make informed decisions about switching from Wegovy to Mounjaro UK based on comprehensive cost understanding. Our GPhC-registered pharmacy (#9012878) offers both treatments with identical clinical assessment standards and next-day delivery service.
Wegovy Pricing Structure for UK Patients Considering Mounjaro
Wegovy's monthly cost progression reflects the mandatory dose escalation schedule designed to minimise side effects whilst optimising efficacy. New patients start at £79.99 monthly for the 0.25mg dose (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), then £99.99 for 1mg (weeks 9-12). The penultimate dose costs £139.99 for 1.7mg (weeks 13-16), before reaching the maintenance 2.4mg dose at £209.99 monthly. These prices include our FIRST40 discount code for new customers, applied automatically at checkout to ensure transparent pricing.
For returning customers switching from Wegovy to Mounjaro UK considerations, our DOSE25 code maintains competitive pricing across both treatment options. Bundle packages offer convenience benefits, such as the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99, reducing order frequency and ensuring treatment continuity. This pricing transparency enables accurate budgeting whether continuing with Wegovy or transitioning to Mounjaro under prescriber guidance.
Clinical Evidence Comparison: Switching From Wegovy to Mounjaro UK
When evaluating switching from Wegovy to Mounjaro UK, clinical trial data provides essential context for decision-making. Wegovy demonstrated significant efficacy in the STEP trial programme, with patients achieving approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed sustained benefits at two years, whilst SELECT trial data revealed a 20% reduction in major cardiovascular events.
Mounjaro's clinical profile stems from different trial populations and methodologies, making direct comparison challenging without prescriber guidance. Both treatments require individual assessment to determine suitability, as clinical response varies significantly between patients. The decision to switch should always involve healthcare professional evaluation of your specific circumstances, treatment response, and clinical goals.
Mechanism Differences: Wegovy's GLP-1 Action vs Mounjaro's Dual Approach
Understanding how Wegovy works helps contextualize switching from Wegovy to Mounjaro UK decisions. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone released after eating. This mechanism reduces appetite by acting on brain appetite centres, promotes earlier satiety after smaller meals, and may reduce food cravings throughout the day. The once-weekly injection provides sustained hormone activity, supporting consistent appetite regulation between doses. Patients often report feeling fuller sooner and experiencing reduced interest in food, particularly high-calorie options.
EverydayMeds Ordering Process for Both Treatment Options
Whether continuing with Wegovy or switching from Wegovy to Mounjaro UK, our streamlined process ensures clinical safety and convenience. The journey begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within three working days (24 hours with express service), ensuring thorough evaluation before approval. Once approved, next-day delivery via temperature-controlled cold-chain logistics maintains medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. This process applies identically whether ordering Wegovy, considering Mounjaro, or managing the transition between treatments under prescriber supervision.
Storage and Practical Considerations for Treatment Switching
Practical factors often influence switching from Wegovy to Mounjaro UK decisions, particularly regarding storage requirements and injection experience. Wegovy offers superior storage flexibility, maintaining stability for up to six weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both utilize user-friendly pre-filled pen devices, though injection volumes and pen designs differ slightly between manufacturers. The FlexTouch pen system for Wegovy features established ergonomics and clear dose display, whilst understanding these practical differences helps ensure smooth treatment transitions. Temperature monitoring becomes crucial during switching periods when managing overlapping supplies of both medications.
Long-term Budget Planning When Switching From Wegovy to Mounjaro UK
Financial planning for weight management medication requires understanding the maintenance phase costs and duration considerations. At Wegovy's maintenance dose of 2.4mg, patients can expect monthly costs of £209.99 with DOSE25 discount code, translating to approximately £2,520 annually for ongoing treatment. The STEP trial extension data suggests weight regain occurs when treatment stops, making long-term financial commitment essential for sustained benefits.
When switching from Wegovy to Mounjaro UK, comparing annual treatment costs alongside clinical factors helps inform decision-making. EverydayMeds bundle options provide cost management tools, such as consistency bundles for maintenance dosing that reduce ordering frequency whilst maintaining supply security. Understanding that weight management represents a long-term commitment helps patients budget appropriately for either treatment pathway.
Making the Switch: Clinical Assessment for Wegovy to Mounjaro Transition
The clinical assessment process for switching from Wegovy to Mounjaro UK requires comprehensive evaluation of current treatment response, side effect profile, and individual circumstances. Our prescribers assess factors including time on current treatment, weight loss achieved, tolerance issues, and clinical goals when considering treatment changes. Both medications are prescription-only medicines requiring ongoing medical supervision throughout the treatment journey. Switching decisions should never be based solely on cost considerations, but rather comprehensive clinical evaluation balancing efficacy, tolerability, and practical factors. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring continuity of care whether continuing current treatment or transitioning under prescriber guidance. Your clinical assessment will determine the most appropriate treatment pathway based on individual medical history and treatment objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
